Table 2 Summary of cAMP assay pEC50 values for CTR ECD alanine mutants at the AMY1(a) receptor (CT(a)/RAMP1) when stimulated with rAmy (rat amylin) or hαCGRP

From: An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacology

AMY 1(a)

rAmy

hαCGRP

Mutant

pEC 50 WT

pEC 50 mutant

Fold shift

pEC 50 WT

pEC 50 mutant

Fold shift

G44A

9.42±0.33 (5)

9.65±0.35 (5)

 

9.98±0.06 (3)

10.13±0.16 (3)

 

R45A

9.35±0.29 (5)

9.44±0.25 (5)

 

9.69±0.33 (3)

9.67±0.31 (3)

 

M48A

9.51±0.21 (4)

9.35±0.13 (4)

 

9.52±0.26 (4)

9.22±0.32 (4)

 

W79A

9.84±0.25 (6)

7.88±0.27 (6)***

91

9.43±0.25 (6)

7.46±0.25 (6)***

93

F99A

9.90±0.08 (5)

9.18±0.23 (5)*

5

10.19±0.12 (5)

9.04±0.26 (5)**

14

D101A

10.05±0.18 (6)

8.22±0.15 (6)***

68

9.74±0.28 (6)

6.90±0.17 (6)***

692

F102A

9.67±0.24 (5)

7.81±0.09 (5)***

72

9.74±0.18 (4)

6.79±0.19 (4)***

891

H121A

9.73±0.18 (5)

9.12±0.09 (5)*

4

9.62±0.15 (5)

8.60±0.14 (5)**

11

N124A

9.74 ±0.19 (4)

9.58±0.19

 

9.31±0.26 (5)

9.02±0.13 (5)

 

R126A

9.35±0.28 (4)

8.48±0.18 (4)*

7

9.48±0.34 (4)

8.37±0.17 (4)*

13

W128A

9.90±0.14 (4)

8.00±0.18 (4)***

79

9.84±0.26 (4)

7.26±0.16 (4)***

380

Y131A

9.74±0.28 (4)

8.47±0.26 (4)*

19

10.11±0.18 (4)

8.64±0.29 (4)**

30

  1. Data are mean±s.e.m. Number of independent experiments indicated in parentheses. *P<0.05; **P<0.01; ***P<0.001 versus WT by unpaired t-test.